Clinical Trials Directory

Trials / Unknown

UnknownNCT05414227

The Association of Gut Microbes and Their Metabolites With Post-stroke Depression

Research on the Association of Gut Microbes and Their Metabolites With Post-stroke Depression

Status
Unknown
Phase
Study type
Observational
Enrollment
200 (estimated)
Sponsor
The Affiliated Hospital of Xuzhou Medical University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

In this study, the clinical data of patients with AIS were collected, 16s RNA was used to detect the composition and diversity of intestinal flora, and flow cytometry and mass spectrometry were used to detect intestinal flora-related metabolites in plasma,to explore the influence of gut microbiota and its metabolites on stroke prognosis.

Detailed description

In recent years, more and more studies have been conducted on the gut-brain axis, and gut microbes can affect the brain by regulating immune responses, metabolites, and neurotransmitters. The composition of gut microbiota may affect stroke prognosis, including focal neurological deficits, cognitive impairment, anxiety and depression, and fatigue. In this study, 16s RNA was used to detect the composition and diversity of intestinal flora, and flow cytometry and mass spectrometry were used to detect intestinal flora-related metabolites in plasma. The clinical data of patients were collected, including age, gender, and medical history, NIHSS, mRS, MMSE, Patient Health Questionnaire-9(PHQ9), Social Support Rating Scale(SSRS), laboratory and radiology results. The neurological recovery of the patients was assessed after 3 and 6 months, and the presence or absence of post-stroke depression(PSD) and post-stroke fatigue(PSF) was assessed by the Hamilton Depression Scale, the Fatigue Severity Scale(FSS) and the Multidimensional Fatigue Scale(MFS). To evaluate the relationship between gut microbiota and its metabolites and stroke prognosis.

Conditions

Timeline

Start date
2022-06-06
Primary completion
2023-02-28
Completion
2023-05-31
First posted
2022-06-10
Last updated
2022-06-10

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05414227. Inclusion in this directory is not an endorsement.